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METHODOLOGY
Fixation methods can differentially affect 
ciliary protein immunolabeling
Kiet Hua1 and Russell J. Ferland1,2* 
Abstract 
Background: Primary cilia are immotile, microtubule-based organelles present on most cells. Defects in primary cilia 
presence/function result in a category of developmental diseases referred to as ciliopathies. As the cilia field pro-
gresses, there is a need to consider both the ciliary and extraciliary roles of cilia proteins. However, traditional fixation 
methods are not always suitable for examining the full range of localizations of cilia proteins. Here, we tested a variety 
of fixation methods with commonly used cilia markers to determine the most appropriate fixation method for differ-
ent cilia proteins.
Methods: Mouse inner medullary collecting duct and human retinal pigmented epithelial cells were grown to 
confluence, serum starved, and fixed with one of the following fixation agents: paraformaldehyde–sucrose, paraform-
aldehyde–PBS, methanol, cytoskeletal buffer followed by methanol, or three variations of cytoskeletal buffer–para-
formaldehyde fixation. Each cell type and fixation method combination was probed with the following ciliary markers: 
acetylated α-tubulin, detyrosinated tubulin, polyglutamylated tubulin, β-tubulin, adenylyl cyclase 3 (AC3), ADP-ribo-
sylation factor-like protein 13b (Arl13b), centrosome and spindle pole associated protein 1 (CSPP1), or intraflagellar 
transport protein 20 (IFT20). Intraflagellar transport protein 88 (IFT88) and GM130 (Golgi marker) were also used. We 
assessed actin (via phalloidin) and microtubule integrity, centrioles, cilia, and two extraciliary sites (mitotic figures and 
Golgi).
Results: For the cilia markers examined, paraformaldehyde fixation preserved cilia immunolabeling of cilia-mem-
brane proteins (AC3 and Arl13b), but failed to reveal cilia immunostaining of axonemal proteins (CSPP1 and IFT20). 
Methanol revealed cilia labeling for some axonemal proteins, but not others, and this depended on cell type. Gener-
ally, any method that first included a wash in cytoskeletal buffer, before fixing, revealed more distinct cilia immuno-
labeling for axonemal proteins (CSPP1, IFT20, and IFT88), but resulted in the loss of cilia labeling for cilia-membrane 
proteins (AC3 and Arl13b). All three different post-translational modifications of tubulin antibodies positively immu-
nolabeled cilia in all fixation methods tested. Ultimately, we found that fixing cells in a solution of paraformaldehyde 
prepared in cytoskeletal buffer allowed for the preservation of cilia immunolabeling for most cilia proteins tested and 
allowed visualization of two extraciliary sites (mitotic figures and Golgi).
Conclusion: Some general patterns were observed to guide in the choice of a fixation agent. Cilia-membrane pro-
teins generally benefit from quick fixation with no prior permeabilization, whereas axonemal proteins tend to benefit 
from permeabilization and use of cytoskeletal buffer.
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Background
Primary cilia are immotile, usually found singularly per 
cell, and are recognized for their roles in signaling and 
development [1]. Structurally, the primary cilium is com-
posed of the basal body and the axoneme [1–4]. The 
basal body is a mature mother centriole that has docked 
to the plasma membrane, and it gives rise to the microtu-
bules that form the cilium [5]. These microtubules form 
the shaft or axoneme of the cilium, and are arranged in 
a 9+0 pattern that consists of 9 doublets of microtubules 
arranged in a circular fashion [6]. This is in contrast to 
motile cilia which have a 9+2 pattern that consists of 
9 microtubule doublets surrounding a central pair of 
microtubules [6]. Primary cilia are organelles and rep-
resent a separate compartment of the cell, meaning that 
the cilia-membrane and cilioplasm are distinct from the 
plasma membrane and cytoplasm, respectively [7]. The 
cilium also has its own transport system, the intraflagel-
lar transport system (IFT), consisting of motor protein 
complexes that carry proteins in an anterograde and ret-
rograde manner along the microtubular axoneme [8]. A 
defect in any of the proteins important for the assembly, 
maintenance and/or function of the primary cilium can 
result in a category of developmental diseases called cili-
opathies [1, 2, 9].
The history leading to our current understanding of 
the primary cilium is partly dependent on technological 
advances. Primary cilia were first observed in 1898 by 
the Swiss anatomist, KW Zimmerman, who drew images 
that depicted the mother and daughter centrioles with 
a primary cilium protruding into the luminal space of 
a kidney tubule [10, 11]. Zimmerman noticed that this 
immotile structure was found one per cell, and named 
it the “centralgeissel”, meaning the central flagellum, 
and surmised that it had a sensory function [11]. How-
ever, it was not until the invention of the electron micro-
scope that this organelle was verified [10, 12]. In 1985, 
Poole et  al. speculated that primary cilia have chemical 
and sensory roles [13], assumptions that have now been 
verified by multiple labs [14–17]. Here, we suggest that 
an important subcategorization within the primary cilia 
field will lie in the study of primary cilia proteins at extra-
ciliary sites [18].
Many cilia proteins localize to cellular sites besides the 
cilium [18]. For example, centrosome and spindle pole 
associated protein 1 (CSPP1) was initially described as 
a centrosome and mitotic spindle protein [19], and was 
later found to also localize in primary cilia [20]. CSPP1 
has now also been found to localize to desmosomes [21] 
and kinetochores [22]. Arl13b is not only found in cilia, 
but also co-labels with endocytic markers [23]. Intra-
flagellar transport protein 20 (IFT20) is another cilia 
marker, and it also localizes to the Golgi [24]. Therefore, 
further research is needed to understand the role of cilia 
proteins at extraciliary sites and how this might contrib-
ute to the underlying pathologies of ciliopathies [18].
Both the microtubule and actin cytoskeleton have 
been shown to be critical for proper primary cilia forma-
tion/function. It is not surprising that the microtubule 
cytoskeleton plays a role in ciliogenesis as the cilium is 
a microtubule-based structure. In fact, CSPP1, a cili-
ogenesis protein, has a microtubule-binding domain [25]. 
Defects in another ciliogenesis protein, Ahi1, have also 
been reported to result in a disorganized microtubule 
cytoskeleton [26], suggesting that Ahi1 may have a role 
in microtubule organization. Moreover, knockdown of 
Ahi1 in IMCD3 cells was shown to result in a disorgan-
ized actin network as well [26]. Actin proteins are now 
increasingly being shown to be important for ciliogen-
esis. Recently, multiple labs reported that non-muscle 
myosin heavy chain 10 (MYH10), an actin regulating 
protein, is also necessary for ciliogenesis [27, 28]. Inter-
estingly, MYH10 does not localize to the basal body or 
axoneme of primary cilia, but loss of MYH10 results in 
loss of cilia [27]. This suggests (1) that proper function-
ing of the microtubule and actin cytoskeleton is neces-
sary for the construction of the primary cilium, and/or 
(2) that at least some cilia proteins also function as more 
general cytoskeletal proteins (i.e., regulators of actin and 
microtubules). Consequently, understanding how differ-
ent fixation techniques alter the actin and microtubule 
cytoskeleton, as well as the primary cilium, is critical for 
understanding ciliopathies.
The effect of fixation on ciliary protein localization via 
immunocytochemistry can be demonstrated with the 
cilia-associated protein, CSPP1 [20]. CSPP1 was initially 
identified as a protein that localizes to centrosomes and 
mitotic spindles [19]. Subsequently, CSPP1 was found to 
localize to primary cilia in methanol-fixed cells [20]. The 
fixation process used is important because paraformal-
dehyde fixation does not reliably yield cilia immunolabe-
ling when using the same CSPP1 antibody (unpublished 
observations). Paraformaldehyde is known to disrupt the 
native conformation of microtubules and can hide cilia 
immunostaining for some cilia markers [29]. This prob-
lem can sometimes be mitigated by use of methanol as 
a fixation agent; however, methanol obscures the phal-
loidin epitope (a widely used reagent to view actin stress 
fibers). Therefore, alternative fixation methods are nec-
essary to allow for the reliable, concurrent viewing of 
microtubules, phalloidin-stained actin stress fibers, and 
cilia markers.
Preservation of the cytoskeleton during fixation 
has historically been achieved through the use of 
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cytoskeleton buffers [30]. In  vitro observations show 
that tubulin polymerized when (1) calcium is absent, 
(2) magnesium is added to the buffer, and (3) when the 
incubation occurred at 35  °C as opposed to 0  °C [31]. 
This led to the development and use of various forms of 
cytoskeletal buffers (also referred to as extraction buff-
ers) that consisted of EGTA (a calcium chelator), mag-
nesium, and Triton X-100 detergent for extraction [32]. 
These cytoskeleton buffers proved useful for studying 
CSPP1 when in 2014, three laboratories published papers 
that showed CSPP1 was a causative gene for Joubert 
syndrome (a neurodevelopmental ciliopathy). However, 
there were discrepancies with two of the laboratories 
reporting different immunolabeling patterns for CSPP1 
[33, 34]. Both laboratories used primary human dermal 
fibroblasts collected from control subjects and indi-
viduals with Joubert syndrome. One laboratory showed 
CSPP1 localization to the centrosomes [33], while our 
laboratory observed CSPP1 localization also at the axo-
neme of the primary cilium [34]. We found that when 
studying CSPP1, a microtubule-stabilizing buffer simi-
lar to cytoskeletal buffer was required to reveal consist-
ent and reliable CSPP1 labeling at the ciliary axoneme 
[34]. These studies indicate that careful consideration 
and understanding of fixation methods are important 
for interpreting localizations of ciliary proteins. For that 
reason, we explored the advantages and disadvantages 
of various fixation methods in a systematic and compre-
hensive attempt to elucidate how these different methods 
affect immunolabeling of popularly used cilia markers. 
Our results would advocate the use of cytoskeletal buff-
ers during cell fixation, which largely preserves labeling 
of cilia, microtubules, actin stress fibers, and at least the 




Mouse inner medullary collecting duct (IMCD3) cells 
and human retinal pigmented epithelial (RPE) cells were 
grown in Dulbecco’s modified Eagle’s medium/nutrient 
mixture F12 (DMEM/F12; Sigma, D8437) and Dulbec-
co’s modified Eagle’s medium (DMEM; Sigma, D5796), 
respectively. In both cases, media were supplemented 
with 10% fetal bovine serum (FBS; Hyclone, SH30070.03) 
and 1% penicillin–streptomycin (Gibco, 15140-122). For 
immunolabeling studies, cells were trypsinized (0.25%), 
seeded, and grown on 12-mm glass coverslips until con-
fluent in a 37 °C incubator with 5% CO2. Upon reaching 
confluence, cells were switched to starvation medium 
(DMEM/F12 or DMEM supplemented with 1% penicil-




Paraformaldehyde was made using powdered PFA 
(Sigma, P6148) that was always stored at 4  °C, and dis-
solved into phosphate-buffered saline (PBS) to a final 
concentration of 4%. The pH of the PFA solution was 
7.0. At the beginning of the experiment, a large batch of 
PFA–sucrose and PFA–PBS was prepared, aliquoted, and 
frozen at −20  °C so that all experiments could be per-
formed with PFA prepared from the same batch. PFA was 
always stored at −20 °C, and only thawed out in aliquots 
when needed. Aliquots were never used for longer than 
1 day after being thawed.
Paraformaldehyde–PBS (PFA–PBS)
Cells were first washed in PBS, and then fixed for 10 min 
at room temperature in a solution of 4% PFA prepared 
in PBS. Cells were again extensively washed, and sub-
sequently blocked for 1  h in 1% bovine serum albumin 
(BSA; Sigma, A7030) prepared in Banker’s PBS [140 mM 
NaCl (Sigma, S9888), 15 mM phosphate buffer] [35] with 
0.1% Triton X-100 (PBS-Tx; Sigma, T9284) for 1  h at 
room temperature.
Paraformaldehyde–sucrose (PFA‑S)
Cells were washed in PBS, and then fixed at room tem-
perature for 10 min in a solution of 4% PFA prepared in 
PBS and 4% sucrose (Sigma, S0389). Cells were exten-
sively washed again, and then blocked in 1% BSA/Bank-
er’s PBS-Tx (0.1%) for 1 h at room temperature.
Methanol (MeOH)
Cells were first washed in PBS, and then fixed with cold 
MeOH (−20 °C; Absolute–Acetone Free; Sigma, M1775) 
inside a −20  °C freezer for 10 min. The plate of cells to 
be fixed was placed directly onto the freezer coils for 
maximum coldness. After being washed again, cells were 
blocked for 1 h at room temperature in 1% BSA/Banker’s 
PBS-Tx (0.1%).
Cytoskeletal buffer (CB) for fixation
Cytoskeletal buffer was prepared with the following com-
ponents: 100 mM NaCl (Sigma, S9888), 300 mM sucrose 
(Sigma, S0389), 3  mM MgCl2 (Sigma, M2670), and 
10  mM PIPES (Sigma, P6757). The pH of this solution 
was adjusted to 6.9. The final CB solution was filtered and 
stored at −20 °C until needed. CB was not used for more 
than 1  day after thawing. Immediately before use, for a 
50 ml volume of CB, 250 µl of Triton X-100 and 250 µl 
of EGTA (1 M) (Sigma, E3889) were added. The CB was 
warmed to 37 °C in a water bath before use. It should be 
noted that any fixation using a CB wash must be done 
quickly or cells will float off the coverslip.
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Cytoskeletal buffer followed by methanol (CB → MeOH)
Cells were quickly washed with cytoskeletal buffer, then 
immediately subjected to fixation with cold MeOH inside 
a −20 °C freezer. Cells were then washed and blocked in 
a 1% BSA/Banker’s PBS-Tx (0.1%) solution for 1 h.
4% paraformaldehyde prepared in cytoskeletal buffer 
(CB‑PFA)
Four percent PFA was prepared in CB. After washing 
with PBS, cells were fixed for 10 min at 37  °C with CB-
PFA. Cells were extensively washed and blocked for 1 h 
at room temperature in 1% BSA/Banker’s PBS-Tx (0.1%).
Cytoskeletal buffer wash followed by 4% paraformaldehyde 
prepared in cytoskeletal buffer (CB → CB‑PFA)
Cells were washed quickly two times with pre-warmed 
CB. CB should be applied, and then removed within a 
few seconds (longer incubations will result in cells float-
ing off the coverslips). Cells were then fixed with CB-PFA 
for 10  min at 37  °C. Cells were extensively washed and 
blocked for 1 h at room temperature in 1% BSA/Banker’s 
PBS-Tx (0.1%).
Cytoskeletal buffer wash, followed by 4% paraformaldehyde 
prepared in cytoskeletal buffer, and a final post‑fixation 
in methanol (CB → CB‑PFA → MeOH)
Cells were washed twice with pre-warmed CB, fixed for 
10 min in CB-PFA, and then post-fixed in ice-cold MeOH 
(−20  °C) for an additional 10  min in a −20  °C freezer. 
Then, cells were extensively washed and blocked for 1 h 
at room temperature in 1% BSA/Banker’s PBS-Tx (0.1%).
Pre‑ and post‑fixation permeabilization
For these experiments, cells were washed in PBS, and then 
fixed for 10  min in PFA-S as described above, but were 
additionally subjected to a permeabilization step either 
before or after being fixed. The following were used for 
permeabilization: Banker’s PBS with 0, 0.04, 0.1, 0.5, 1% 
Triton X-100, or CB. For pre-fixation permeabilization, 
cells were simply washed quickly with the permeabiliza-
tion solutions before being fixed. These washes must be 
done quickly to avoid cells detaching from the coverslip. 
For post-fixation permeabilization, cells were fixed first in 
PFA-S, and then permeabilized with one of the permeabi-
lization solutions. In both cases, cells were later extensively 
washed, blocked, and incubated in solutions containing 
the same concentration of Triton X-100 as their treatment 
group, with the exception of the CB group, which was 
treated with 0.1% Triton X-100 for all post-fixation steps.
Immunofluorescence
After the above fixation methods, cells were incubated 
in a primary antibody solution prepared in 1% BSA and 
Banker’s PBS-Tx (different concentrations of Triton 
X-100 were used depending on the experiment) overnight 
at 4 °C. Primary antibodies used, included rabbit anti-β-
tubulin (1:1000, Abcam, ab6046), mouse anti-acetylated 
α-tubulin (1:50,000, Sigma, clone 6-11B-1), rabbit anti-
detyrosinated tubulin (1:500, Millipore, AB3201), mouse 
anti-polyglutamylated tubulin (1:500, Sigma, T9822), 
rabbit anti-adenylyl cyclase 3 (AC3, 1:200, Santa Cruz 
Biotechnology, sc-588), rabbit anti-ADP-ribosylation fac-
tor-like protein 13b (Arl13b, 1:200, UC Davis/NIH Neu-
roMab Facility clone N295B/66), rabbit anti-centrosome 
and spindle pole associated protein 1 (CSPP1, 1:200, 
Proteintech, 11931-1-AP), rabbit anti-intraflagellar trans-
port protein 20 (IFT20, 1:200, Sigma, HPA021376), rab-
bit anti-intraflagellar transport protein 88 (IFT88, 1:200, 
Proteintech, 13967-1-AP), and mouse anti-Golgi matrix 
protein 130 (GM130, 1:1,000, BD Bioscience, 610822). 
After extensive washing, cells were then incubated in 
either mouse or rabbit Alexafluor 488 and Alexafluor 546 
secondary antibodies (1:500, Life Technologies) for 1 h at 
room temperature. Last, nuclei were labeled with Hoe-
chst 33258 (1  µg/ml), and actin was labeled with phal-
loidin-546 (1:200, Sigma, A22283) when appropriate. All 
coverslips were mounted with Fluoromount G (Southern 
Biotech, 0100-01). Images were obtained with a Zeiss 
AxioImager.Z1 upright microscope equipped with an 
AxioCam MRm camera, using a 63× plan-apochromat 
(1.4 NA) oil objective (Zeiss) and fluorescent filter sets 
20, 34, 38HE, and 50 (Zeiss). Images were processed with 
AxioVision Rel. 4.5 software, and imported into ImageJ 
[36] and/or Adobe Photoshop CS6 version 13.0 × 64 to 
assemble montages.
Results
Different fixation methods affect microtubule 
immunolabeling and phalloidin staining of actin stress 
fibers
Microtubules as assessed with β-tubulin antibody 
appeared to be preserved, though to different extents, 
with all fixation methods tested (PFA-S; PFA-PBS; 
MeOH; CB-PFA; CB  →  MeOH; CB  →  CB-PFA; 
CB  →  CB-PFA  →  MeOH) in RPE and IMCD3 cells 
(Fig.  1; Table  1). Moreover, β-tubulin antibody labeled 
the cilium to varying degrees in the tested fixation meth-
ods (Fig. 1; Table 1). Methods that did not include a pre-
CB wash (PFA-S, PFA-PBS, MeOH, and CB-PFA) yielded 
positive staining throughout the cell cytoplasm and at the 
cilium. But, especially when fixed with PFA-S or PFA-
PBS, the bright labeling of microtubules in the cytoplasm 
often obscured the presence of a cilium. The opposite 
was found with fixation methods that included a CB wash 
before cells were fixed (CB → MeOH, CB → CBPFA, or 
CB → CBPFA → MeOH). Washing cells with CB (Fig. 1) 
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or with detergent (Fig. 2) yielded little cytoskeletal micro-
tubule staining, and thus, made cilia immunolabeling 
more prominent. Caution is needed, however, when 
using a high concentration of Triton X-100 when apply-
ing a pre-wash because it often led to loss of cells on the 
coverslip. Not using Triton X-100 at all was also not an 
option, as evidence by our 0% Triton X-100 treatment 
groups, which showed only sporadic microtubule stain-
ing and no cilia localization with the β-tubulin antibody 
(Fig. 2).
Fig. 1 Different fixation methods affect microtubule immunolabeling and phalloidin staining of actin stress fibers in IMCD3 and RPE cells. IMCD3 
and RPE cells, subjected to various fixation methods, were labeled for microtubules (β-tubulin, green), actin stress fibers (phalloidin, red), and nuclei 
staining (Hoechst, blue). Cilia and microtubules were preserved in both IMCD3 and RPE cells to varying extents in all fixation methods. Phalloidin 
staining of stress fibers was not preserved in the MeOH, CB → MeOH, and the CB → CBPFA → MeOH groups for both cell lines, but was preserved 
in all other fixation groups. Scale bars 10 µm
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Actin stress fibers as assessed with phalloidin staining 
were not preserved when using any fixation method that 
included the use of methanol (MeOH, CB → MeOH, or 
CB → CB-PFA → MeOH), but were intact with PFA-S, 
PFA-PBS, CB-PFA, or CB →  CB-PFA fixation methods 
(Fig. 1).
Different fixation methods affect cilia marker 
immunolabeling localizations
To test these various fixation methods and their effects 
on ciliary compartment labeling, we chose antibodies 
that labeled the structural components of the microtu-
bule axoneme (acetylated α-tubulin, detyrosinated tubu-
lin, and polyglutamylated tubulin), proteins bound to the 
axoneme (CSPP1 and IFT20), and ciliary membrane pro-
teins (AC3 and Arl13b).
All three antibodies tested that were targeted to 
post-translational modifications on tubulin (acetylated 
α-tubulin, detyrosinated tubulin, and polyglutamyl-
ated tubulin) produced cilia labeling to varying degrees 
of success when subjected to different fixation methods 
(Fig. 3; Table 1). We observed that fixation methods that 
employed the use of methanol (MeOH, CB  →  MeOH, 
and CB  →  CBPFA  →  MeOH) tended to increase the 
presence of centrosomal staining at the base of cilia in 
both IMCD3 and RPE cells (Fig.  3). While cilia labeling 
appears prominently for the three antibodies in most 
cases (Fig. 3), staining showed a difference especially with 
polyglutamylated tubulin antibody (Fig.  3). In IMCD3 
and RPE cells, both acetylated α-tubulin and detyrosi-
nated tubulin showed prominent cilia labeling across all 
fixation methods tested (Fig. 3). When probing for poly-
glutamylated tubulin, however, the microtubule labeling 
with this antibody was intense, making it difficult to find 
and identify cilia, especially in methanol-treated cells (for 
both IMCD3 and RPE cells) and in the CB →  CB-PFA 
group (in RPE cells) (Fig. 3).
In IMCD3 cells, PFA-S fixation reliably revealed cili-
ary labeling with the Arl13b antibody, and to a lesser 
extent, preserved less distinct cilia immunolabeling 
with the CSPP1 antibody in some cells (Fig. 4; Table 1). 
PFA-S fixation also preserved prominent AC3 labeling 
at the mother and daughter centrioles, and could also be 
observed less intensely in some cilia (Fig. 4). PFA-S fixa-
tion did not yield ciliary or basal body immunolabeling 
for IFT20 (Fig. 4). IFT88, unlike other axoneme proteins 
tested, labeled cilia in all fixation methods tested (Fig. 5). 
These PFA-S observations were identical in RPE cells, 
including the labeling for CSPP1 in cilia not being seen 
in all cells and not as distinct (Fig.  6; Table  1). Results 
obtained with PFA-PBS fixation were indiscernible from 
PFA-S fixation for both cell types (Figs. 4, 6).
While many laboratories have had success with MeOH 
fixation, our results demonstrated that MeOH fixation 
Table 1 Summary of fixation methods and their effects on cilia marker immunolabeling
−, no cilia staining; +/−, some, but not all cells have cilia staining; +, cilia staining is present, but not obvious (i.e. high background); ++, easily noticeable cilia 
staining; +++, cilia staining is bright with low background
Antibodies Cilia staining
PFA-S PFA/PBS MeOH CBPFA CB MeOH CB CBPFA CB CBPFA MeOH
IMCD3
β-tubulin + + + + ++ +++ +++
Acetylated-α- tubulin +++ +++ ++ +++ +++ +++ +++
Detyrosinated tubulin +++ +++ +++ + + +++ +++
Polyglutamylated tubulin + + +/− +++ +++ +++ +++
AC3 + + − − − − −
Arl13b +++ +++ + +++ − − −
CSPP1 +/− +/− – ++ – + +++
IFT20 − − − − + + +
RPE
β-tubulin +/− + + + ++ +++ +++
Acetylated-α-tubulin +++ +++ +++ +++ +++ +++ +++
Detyrosinated tubulin +++ +++ +++ +++ +++ +++ +++
Polyglutamylated tubulin ++ +++ +/− ++ +++ +/− +++
AC3 − − − − − − −
Arl13b +++ +++ − +++ − − −
CSPP1 + + − +++ − +++ +
IFT20 − − − +/− + ++ +++
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was the least reliable and replicable fixation method 
attempted. With MeOH fixation, cilia labeling could 
be observed for Arl13b in IMCD3 cells (Fig. 4), but not 
in RPE cells (Fig.  6). AC3 was localized at mother and 
daughter centrioles with MeOH fixation in IMCD3 
(Fig. 4) and RPE cells (Fig. 6). CSPP1 only immunolabeled 
Fig. 2 Permeabilization before or after PFA fixation affects microtubule immunolabeling in IMCD3 and RPE cells. Cells were either (1) washed with 
a permeabilizing solution before being fixed with PFA-S, or (2) fixed with PFA-S, and then permeabilized with solutions of different strength. Cilia 
immunolabeling was assessed with a β-tubulin antibody (green) and Hoechst dye for nuclear staining (blue). No permeabilization resulted in little 
or absent cilia labeling and sporadic microtubule cytoskeleton staining. Permeabilization of any strength resulted in robust cilia labeling and micro-
tubule staining. Permeabilization strength was negatively correlated with the preservation of microtubule labeling, although CB which contains 
0.5% Triton X-100 appears to offer some benefit to microtubule preservation. Permeabilization done after cells were already fixed did not affect 
microtubule or cilia immunolabeling. Scale bars 10 µm
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centrioles in IMCD3 (Fig. 4) and RPE (Fig. 6) cells with 
MeOH fixation. For IFT20 immunolabeling with MeOH 
fixation, no cilia or centrosomal labeling was observed 
for either cell type (Figs. 4, 6).
Of all the variations using CB fixation, all antibodies 
produced similar immunolabeling patterns in both cell 
lines. AC3 only labeled centrioles (Figs.  4, 6; Table  1). 
Arl13b did not label cilia in the CB → MeOH, CB → CB-
PFA or CB  →  CB-PFA  →  MeOH fixation groups in 
either cell line, but CB-PFA fixation did preserve cilia 
immunolabeling in both cell lines similar to PFA (Figs. 4, 
6; Table  1). CSPP1 produced distinct centrosome labe-
ling with all the CB variation methods and yielded cilia 
immunolabeling in IMCD3 and RPE cells with vary-
ing levels of intensity (Figs. 4, 6; with CB-PFA being the 
most consistent across cell lines). The exception was 
CB → MeOH fixation which did not label cilia in either 
cell type (Figs. 4, 6; Table 1). IFT20 showed unreliable cilia 
labeling with CB-PFA fixation, but produced distinct cilia 
staining in all other CB fixation methods (CB → MeOH, 
CB  →  CBPFA, and CB  →  CBPFA  →  MeOH) tested 
(Figs. 4, 6; Table 1).
Different fixation methods affect mitotic figure labeling
Microtubules that make up the mitotic spindles, as 
assessed by acetylated α-tubulin immunostaining, 
Fig. 3 Different fixation methods and its effects on structural tubulin post-translational protein immunolabeling of cilia in IMCD3 and RPE cells. 
IMCD3 and RPE cells were fixed with various fixation methods, and then probed with: acetylated-α-tubulin, detyrosinated tubulin, or polyglutamyl-
ated tubulin antibody. Cilia staining was preserved in all groups to varying levels of success. Panels denoted by asterisk have rare and difficult to 
identify cilia immunolabeling. Scale bars 5 µm
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Fig. 4 Different fixation methods affect cilia marker immunolabeling in IMCD3 cells. IMCD3 cells were fixed with various fixation methods and then 
probed with AC3, Arl13b, CSPP1, and IFT20 antibodies (red). All coverslips were also co-stained with acetylated-α-tubulin (green) for cilia labeling 
and Hoechst for nuclear labeling (blue). Insets are separated channel images at 50% of the original image. Generally, cilia immunolabeling was best 
observed for the membrane-localizing proteins (AC3 and Arl13b) in the PFA-S group, while axoneme-localizing proteins (CSPP1 and IFT20) were 
best preserved in cilia treated with CB fixation methods. Scale bars 5 µm
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were preserved in both cell lines with all fixation meth-
ods, but with noticeable differences (Fig.  7). IMCD3 
cells that were treated with methanol (MeOH and 
CB →  CBPFA →  MeOH) have distorted DNA labeling 
(Hoechst) and less intense mitotic spindle staining. How-
ever, MeOH fixation, for both IMCD3 and RPE cells, 
showed the most distinct and reproducible centroso-
mal immunolabeling with acetylated α-tubulin antibody 
(Fig.  7). All other fixation groups tested showed some 
centrosomal labeling, but this was only found in a minor-
ity of cells and displayed much less intense labeling at 
centrosomes (Fig. 7).
With the exception of IFT20, mitotic figures were 
largely obscured in a poorly defined haze when cells 
were fixed with PFA-S (Fig.  7). IMCD3 and RPE cells 
fixed with MeOH revealed intense centrosomal labeling 
with CSPP1, mitotic spindle labeling with IFT20, but no 
distinct immunolabeling with Arl13b (Fig.  7). Metha-
nol-fixed RPE cells also showed centrosomal staining in 
mitotic figures with AC3 antibody. CB fixation methods 
produced consistent immunolabeling across both cell 
lines for the antibodies tested. AC3 labeled positive for 
centrosomes and weakly for mitotic spindles in RPE and 
IMCD3 cells, while CB fixation techniques did not reveal 
any mitotic figure labeling with Arl13b for either cell line 
(Fig.  7). CSPP1 immunolabeled centrosomes, and both 
CSPP1 and IFT20 labeled mitotic spindles in both cell 
lines when fixed with either variation of CB fixation. For 
this set of experiments, we excluded the PFA–PBS group 
since we do not observe any differences between PFA-S 
and PFA–PBS. We also excluded the CB → MeOH group 
because it was less reliable and resulted in a higher per-
centage of cell loss from the coverslips.
Different fixation methods affect IFT20 labeling at cis-Golgi
IFT20 co-labels with GM130, a cis-Golgi marker, in 
IMCD3 and RPE cells when cells are fixed with methanol 
or CB-PFA (Fig. 8). Other fixation groups tested yielded 
either non-distinct or absent IFT20 staining (Fig.  8) 
around the cell nucleus (PFA-S, PFA-PBS, CB → MeOH, 
CB → CB-PFA, and CB → CB-PFA → MeOH). GM130 
immunolabeling was also affected by the fixation method 
used, and was often observed to have a washed out 
appearance in the CB treatment groups, especially in RPE 
cells (Fig. 8).
Discussion
It is becoming increasingly clear that cilia proteins can 
also have extraciliary localizations and functions [18, 
26, 37, 38]. Further work is needed to determine which 
ciliary proteins have extraciliary functions, and whether 
these extraciliary functions of cilia proteins contribute to 
the pathology of ciliopathies. If so, what symptoms can 
be attributed to defective cilia, and what symptoms are 
related to defects at extraciliary sites? As these questions 
are explored and the function of these extraciliary sites 
for ciliary proteins is revealed, an understanding of how 
fixation affects immunofluorescent labeling is warranted. 
As described earlier, an inadequate exploration of fixation 
techniques has led to contradictory conclusions by differ-
ent laboratories. CSPP1 has been reported to be exclu-
sively a centrosomal protein [33], exclusively an axonemal 
protein [34], or both a centrosomal and an axonemal pro-
tein [20] depending upon the fixation method used. Even 
widely used antibodies like anti-acetylated α-tubulin can 
produce differing results depending on the method of fix-
ation utilized. The acetylated α-tubulin antibody immu-
nolabels both cilia and centrosomes in MeOH-fixed cells, 
but in PFA-fixed cells, immunolabeling reveals only cilia 
with a few cells exhibiting centrosomal labeling. There-
fore, here we wanted to conduct a comprehensive and 
systematic examination of the effects of fixation on ciliary 
marker immunolabeling.
The goal of this study was to establish a reliable and 
flexible fixation technique that could concurrently visual-
ize cilia, microtubules, and actin stress fibers (as assessed 
Fig. 5 Different fixation methods affect IFT88 immunolabeling at cilia in IMCD3 cells. IMCD3 cells were subjected to various fixation methods and 
then co-labeled with IFT88 (red) and acetylated-α-tubulin (green). All coverslips were also stained with Hoechst for nuclear labeling (blue). IFT88 
labels the cilium in all fixation methods tested. Scale bars 5 µm
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Fig. 6 Different fixation methods affect cilia marker immunolabeling in RPE cells. RPE cells were subjected to various fixation methods and then 
probed with AC3, Arl13b, CSPP1, and IFT20 antibodies (red). All coverslips were also co-stained with acetylated-α-tubulin (green) for cilia labeling 
and Hoechst for nuclear labeling (blue). Insets are separated channel images at 50% of the original image. Generally, cilia immunolabeling was best 
observed for the membrane-localizing proteins (AC3 and Arl13b) in the PFA-S group, while axoneme-localizing proteins (CSPP1 and IFT20) were 
best preserved in cilia treated with CB fixation methods. Scale bars 5 µm
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Fig. 7 Different fixation methods affect mitotic figure labeling in IMCD3 and RPE cells. IMCD3 and RPE cells were fixed with various fixation meth-
ods, and then probed with acetylated-α-tubulin to establish images of metaphase mitotic figures when subjected to different fixation methods. 
Separate coverslips of cells were subjected to labeling with either a membrane-bound cilia marker (AC3, Arl13b; green) or an axoneme-bound cilia 
marker (CSPP1, IFT20; green). All cells were stained with Hoechst for nuclear labeling (blue). A In IMCD3 cells, Arl13b did not immunolabel mitotic 
figures, but CSPP1, IFT20, and AC3 labeled mitotic spindles and/or centrosomes depending on the fixation method used. MeOH-treated IMCD3 
cells produced the most intense centrosomal immunolabeling for CSPP1. B In RPE cells, Arl13b also did not label mitotic figures with any tested 
fixation method. Scale bars 10 µm
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with phalloidin). However, current results demonstrate 
that each fixation method has advantages and disadvan-
tages, and it may be necessary to use different fixation 
methods when studying different areas of a cell even 
when studying the same protein. For example, PFA-S fix-
ation reveals AC3 to be at the primary cilium in IMCD3 
cells, but when used to look at mitotic figures, AC3 only 
labels centrioles. However, if the goal was to examine 
AC3 immunolabeling at mitotic figures and not cilia, 
then any of the CB fixation methods would be preferable 
over PFA-S as these methods reveal AC3 localization to 
the mitotic spindles as well as the centrosomes; a finding 
that is novel to our knowledge. Unfortunately, the CB 
fixation methods result in a loss of primary cilia stain-
ing with the AC3 antibody, so we were unable to find one 
fixation protocol that could reveal all of the ciliary and 
extraciliary localizations for AC3. Therefore, the fixation 
method used will be dependent on the antibody and the 
cellular structure that is being studied.
By utilizing the two workhorse cells in the cilia field, 
mouse IMCD3 and human RPE cells, we have found 
that for some cilia markers, immunolabeling patterns 
are dependent on the fixation technique used and can be 
cell type specific. Comparison of two different cell types 
Fig. 8 Different fixation methods affect IFT20 labeling of cis-Golgi in IMCD3 and RPE cells. IMCD3 and RPE cells were subjected to various fixation 
methods and then co-stained with IFT20 (green) and GM130 (a cis-Golgi marker; red). All coverslips were also stained with Hoechst for nuclear labe-
ling (blue). Co-labeling was only observed in the methanol and CB-PFA groups. Scale bars 10 µm
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allows for the examination of potential cell type differ-
ences, but attention is warranted as to how much we can 
extrapolate from these findings. IMCD3 and RPE cells 
are both epithelial type cells, but IMCD3s are mouse 
kidney cells whereas RPE cells are derived from human 
eye. Therefore, any difference we see between RPE and 
IMCD3 protein expression patterns could be due to cell 
type differences, species differences, or antibody binding 
differences. It is beyond the scope of this manuscript to 
examine more cell types to tease out these differences, 
especially since we wanted to use already established 
ciliary cell lines. However, our results indicate that each 
cell line utilized should undergo some degree of trou-
bleshooting for the best fixation methodology to use 
with the hope that our approach provides some directed 
guidance.
Of the four ciliary markers we examined, Arl13b and 
AC3 were directed against mouse epitopes, and IFT20 
and CSPP1 were directed against human epitopes. 
Arl13b was the only monoclonal antibody with the three 
remaining antibodies being polyclonal antibodies. Differ-
ences in human vs. mouse reactive epitopes among anti-
bodies can sometimes yield staining differences, but we 
did not observe any in our data when comparing IMCD3 
and RPE cells. For example, CSPP1 is directed against 
human CSPP1 protein, but it does not appear to label 
human RPE cells any better than in the mouse IMCD3 
cell line. As a whole, our data comparing cilia protein 
immunostaining in IMCD3 and RPE cells look remark-
ably similar.
When we applied a 10-min fixation incubation time for 
all fixation methods to both cell types, we found over-
all that RPE cells maintained a more intact microtubule 
cytoskeleton. This may not only be due to cell type-spe-
cific differences in structural resilience of the microtu-
bule cytoskeleton to fixation agents, but may also be due 
to the fact that IMCD3 cells are smaller than RPE cells. 
Thus, it may be necessary to empirically determine the 
proper fixation method and incubation period for each 
individual cell type and fixation method used in a study. 
Here, by applying the same 10-min incubation period for 
all experiments, we hoped to gain a general understand-
ing of how various fixation agents affected the immuno-
labeling pattern for some popularly used cilia markers.
We fixed our cells at three different temperatures: 
−20 °C for methanol fixation, room temperature for PFA 
fixation techniques, and 37  °C for cytoskeletal buffer-
based techniques. We chose these temperatures based 
on what is most appropriate for each individual fixation 
agent. Methanol must be used cold. PFA is traditionally 
used at room temperature. CB and CB-PFA were used at 
37  °C because Weisenberg showed that in  vitro tubulin 
polymerizes better at more physiological temperatures 
[31]. However, the temperature at which a cell is fixed 
may influence the resulting immunolabeling pattern, 
since colder fixation temperatures may benefit proteins 
that are susceptible to rapid degradation. While it is 
possible that the different temperatures of wash buffers 
and fixatives utilized in our experiments may affect cilia 
immunostaining, we avoided straying from conventional 
temperatures used for these fixation agents to stay con-
sistent with what is already done in the field. However, 
temperature of washes and fixation could be an impor-
tant variable for consideration in examining ciliary and 
extraciliary immunolabeling localizations.
We examined a variety of different fixation techniques 
to see which methods were amenable to actin stress fiber 
staining by phalloidin, microtubule and cilia staining by 
β-tubulin, and three antibodies directed towards tubulin 
post-translational modifications. We found that acety-
lated α-tubulin labeled microtubules comparably with all 
fixation methods used, but the MeOH-fixed cells had the 
distinction of having much more prominent centriolar 
labeling at the base of cilia. Using a CB wash before fixing 
cells also offers a more “washed out” cytoplasmic appear-
ance, offering greater contrast between microtubules and 
a cleared cytoplasm. Phalloidin labeling was preserved 
in fixation methods that did not use MeOH (PFA-S, 
CB →  CB-PFA, and CB-PFA), but was damaged in any 
method that used MeOH regardless of whether MeOH 
was used alone or after being fixed with CB and PFA. 
Thus, CB does not damage phalloidin staining of actin 
stress fibers, since they were preserved in both the CB-
PFA and CB → CB-PFA fixation groups. But PFA-S did 
not protect the phalloidin epitope from MeOH, since the 
CB → CB-PFA → MeOH fixation group lost actin stress 
fiber labeling as assessed by phalloidin. Finally, we saw 
no benefit in using MeOH over PFA since PFA fixation 
techniques offered more replicable results and have the 
advantage that it does not damage the phalloidin epitope.
In this manuscript, we purposely chose commonly 
used and published ciliary markers that are already estab-
lished by others in the field. We also are cautious to not 
make any functional claims about any protein. We do 
note the location of each protein as it differs from one 
fixation method to the other to illustrate that fixation 
methods can affect the staining pattern of an antibody. 
But we acknowledge that each finding in this paper must 
be empirically verified to determine the functional signif-
icance of these localizations through knockout or knock-
down studies to draw any conclusions about the function 
of a protein and the specificity of an antibody.
When our assortment of fixation methods was tested 
against our selection of cilia markers, a pattern was 
quickly noticed that may be generally applicable to other 
ciliary antibodies. The cilia markers appear to be able to 
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be separated into three distinct groups: (1) tubulin struc-
tural markers, (2) membrane-associated proteins, and 
(3) axoneme-associated proteins (Fig. 9). All three post-
translational modification antibodies and the β-tubulin 
antibody immunolabeled cilia regardless of the fixation 
method used although some were more effective than 
others. It appears that structural proteins or at least 
epitopes for these structural proteins are stable against 
PFA, methanol, and variations of cytoskeletal buffer fixa-
tion techniques. Conversely, membrane-bound proteins 
(AC3 and Arl13b) were best preserved at cilia when 
immunolabeled after PFA fixation. Arl13b cilia immu-
nolabeling was also observed in IMCD3 and RPE cells 
that were fixed with MeOH or CB-PFA. We surmise that 
by combining CB with PFA, to make a 4% CB-PFA fixa-
tion solution, we were able to combine the cytoskeletal 
stabilizing benefits of CB along with the quick fixation 
properties of PFA, preserving Arl13b localization at cilia 
before any harsh membrane-washing could take place. 
But fixation methods that used a CB pre-wash appear to 
have washed away the Arl13b and AC3 cilia labeling. It 
is interesting that while CB-PFA fixation was able to pre-
serve Arl13b labeling at cilia, it could not preserve AC3 
cilia immunolabeling, suggesting that this method has its 
limitations. Last, axoneme-associated proteins (CSPP1 
and IFT20) unreliably immunolabel cilia when fixed with 
PFA, but are revealed as cilia markers when cells are fixed 
with either of the CB fixation methods. This suggests that 
either (1) CB stabilizes the epitope of axoneme-associ-
ated proteins, or (2) CB washes away the cilia membrane 
to allow antibodies to access the axoneme-associated 
proteins for labeling. The former hypothesis is more 
likely since tubulin structural markers, which reside 
along the axoneme, are accessible without the use of CB. 
In addition, when we applied our fixation guidelines to 
IFT88, we found that IFT88 defies our categorization as 
it immunolabels cilia when fixed with PFA alone, metha-
nol, or cytoskeletal buffer-based techniques. However, 
we observed that IFT88 labels the cilium more distinctly 
when CB is used, so while CB may not be necessary to 
observe IFT88-positive cilia, CB can be used to help 
improve cilia immunolabeling.
The MeOH-fixed groups were the least replicable of 
the fixation methods we tested, and therefore, were the 
most difficult groups to characterize. Moreover, MeOH is 
still not an ideal fixation agent for our goals as it results 
in distorted DNA labeling, and obscures the epitope for 
phalloidin. Finally, MeOH fixation does not fit our cat-
egorization of membrane-localizing and axoneme-local-
izing proteins as it preserves some but not all proteins 
from each group.
Our goals for this paper were to demonstrate the 
importance of fixation on cilia protein immunolabeling, 
and to establish guidelines that may help others opti-
mize their fixation protocols for studying cilia proteins at 
ciliary and extraciliary sites. While we could not analyze 
all the many extraciliary sites now known in the field to 
be important for cilia proteins, we did choose two sites 
Fig. 9 Summary of general fixation guidelines. PFA fixation preserved 
most membrane-localized cilia proteins and tubulin post-translational 
modification immunolabeling. Application of a cytoskeletal buffer 
(CB) wash or pre-fixation permeabilization with Triton X-100 (not 
shown) washed away many membrane-cilia proteins, but revealed 
axonemal-cilia and post-translational modification immunolabeling. 
Fixation in PFA prepared in CB (CB-PFA) almost always preserved 
membrane-cilia proteins, axonemal-cilia proteins, and post-transla-
tional modification of tubulin immunolabeling
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to examine our fixation methods in (1) mitotic figures 
and (2) cis-Golgi. Mitotic figures are similar to cilia in 
that they consist of microtubules that extend from cen-
trosomes, so it is not surprising that many proteins that 
localize to the cilium and mother/daughter centrioles 
are also found at mitotic figures. Microtubules of mitotic 
figures proved to be similar to microtubules of the 
cytoskeleton in that a tubulin structural marker, acety-
lated α-tubulin, was able to immunolabel them with all 
fixation methods tested. Cilia protein labeling at mitotic 
figures was observed as expected with varying degrees 
of distinctiveness depending on the fixation method 
used: CSPP1 and IFT20 labeled the microtubules, AC3 
labeled the centrosomes, and Arl13b did not label any 
part of the mitotic figure. Interestingly, AC3 appears to 
label the microtubules of the mitotic figure in CB fixation 
groups, a finding that is novel to our understanding, and 
requires further investigation to verify. The methanol and 
CB groups revealed less background staining when com-
pared to the PFA-S group, making the microtubule and 
centrosome staining more distinct.
Fixation methods also affected IFT20 staining at 
the Golgi. IFT20 is known to localize at the Golgi and 
has been observed at the Golgi in PHEM-treated cells 
(another version of a cytoskeletal buffer) and methanol-
treated cells [24]. Our results were similar. IFT20 co-
localized with GM130, a cis-Golgi marker, only when 
IMCD3 and RPE cells were treated with methanol or 
CB-PFA. Fixation methods also appear to affect GM130 
staining as GM130 labeling was often lost in the CB 
fixation groups. Altogether, these results show that not 
unlike at the cilium, cilia protein localization at extracili-
ary sites is also affected by the fixation method used.
When looking at the totality of our data, no one fixa-
tion method can be used to preserve all groups of cilia 
proteins, but CB-PFA comes close. CB-PFA is suitable for 
use when staining for microtubules, phalloidin-stained 
actin stress fibers, most cilia proteins we tested, and for 
at least two extraciliary sites (mitotic figures and IFT20 
labeled Golgi). CB-PFA preserved Arl13b (a membrane-
associated protein) and CSPP1 (an axoneme-associated 
protein) staining at cilia, but it appears to wash away AC3 
cilia labeling, and it is not a reliable method for IFT20 
cilia staining. This discrepancy in cilia immunolabeling 
within each cilia protein group is not straightforward, 
but intriguing. Could AC3 be more vulnerable to being 
washed off the cilia membrane than Arl13b? Are there 
different compartments of varying stabilities on a ciliary 
membrane much like lipid rafts exist as distinct compart-
ments on the plasma membrane? Finally, it is also note-
worthy that while IFT20 lightly and unreliably labels cilia 
in CB-PFA-fixed cells, cilia staining with ITF20 is dra-
matically improved when a CB pre-wash is utilized. A CB 
pre-wash is harsher than fixing with CB-PFA alone, so 
this might suggest that the location of IFT20 on the cili-
ary axoneme requires harsher permeabilization to access 
than CSPP1? Such questions require further study and 
may be elucidated through an understanding of different 
fixation techniques.
Conclusions
As the cilia field moves forward in examining non-ciliary 
sites and as the field continues to expand, it is useful to 
consider and appreciate alternate fixation methods. Our 
findings have revealed a level of complexity in cilia pro-
teins that suggests cilia proteins can be separated into 
different groups and each group benefits from different 
fixation methods. Structural proteins like β-tubulin and 
the various post-translational modification markers are 
resilient to various fixation methods. Cilia-membrane 
proteins are best fixed with PFA alone, but axonemal pro-
teins are often obscured with PFA fixation and benefit 
from CB fixation (Fig. 9). The most universal method we 
found was the CB-PFA method (however, there can be 
exceptions; Fig.  9). CB-PFA appears to be the most ver-
satile of the fixation methods we tested as it preserves the 
microtubule cytoskeleton, phalloidin labeled actin stress 
fibers, and most cilia labeling. This method can also easily 
be adjusted to reveal more distinct cilia labeling by adding 
a CB wash to the protocol, though this can come at a cost 
(e.g., loss of Arl13b labeling). Although there are caveats 
for using any fixation method, we advocate the usage of 
cytoskeleton buffer as a starting point, since the primary 
cilium is essentially a cytoskeletal organelle composed of 
microtubules extending from the cytoskeleton of the cell.
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